Most importantly, the IL-4- and IL-13-induced upregulation of MMP12 at mRNA and protein level was significantly attenuated in M2 macrophages from AD patients treated with dupilumab when compared to cells from untreated patients (Figures 4B, C). This evidence concerns the gene IL4 and Alzheimer disease.